• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板生成素信号传导的分子机制。

Molecular mechanisms of thrombopoietin signaling.

作者信息

Kaushansky K

机构信息

Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0671, USA.

出版信息

J Thromb Haemost. 2009 Jul;7 Suppl 1:235-8. doi: 10.1111/j.1538-7836.2009.03419.x.

DOI:10.1111/j.1538-7836.2009.03419.x
PMID:19630807
Abstract

The molecular pathways that regulate thrombopoiesis are becoming increasingly understood. Upon binding to its receptor, the product of the c-Mpl proto-oncogene, thrombopoietin activates a number of secondary messengers that promote cell survival, proliferation and differentiation. Amongst the best studied are the signal transducers and activators of transcription, phosphoinositol-3-kinase, and the mitogen-activated protein kinases. Additional signals activated by these secondary mediators include mammalian target of rapamycin, beta-catenin, hypoxia-inducible factor 1alpha and the homeobox proteins HOXB4 and HOXA9, and a number that are reduced, including glycogen synthase kinase 3alpha and the FOXO3 family of forkhead proteins. More recently, a number of signaling pathways have been identified that turn the thrombopoietin signal off, a step necessary to avoid uncontrolled myeloproliferation, and include the phosphatases PTEN, SHP1 and SHIP1, the suppressors of cytokine signaling, and down-modulation of surface expression of c-Mpl. This review will focus on these pathways in normal and neoplastic hematopoiesis.

摘要

调节血小板生成的分子途径正越来越为人所了解。血小板生成素与其受体(原癌基因c-Mpl的产物)结合后,会激活多种促进细胞存活、增殖和分化的第二信使。其中研究得最为深入的是转录信号转导子和激活子、磷脂酰肌醇-3-激酶以及丝裂原活化蛋白激酶。这些第二介质激活的其他信号包括雷帕霉素哺乳动物靶蛋白、β-连环蛋白、缺氧诱导因子1α以及同源框蛋白HOXB4和HOXA9,还有一些信号减少,包括糖原合酶激酶3α和叉头蛋白FOXO3家族。最近,已经确定了一些使血小板生成素信号关闭的信号通路,这是避免不受控制的骨髓增殖所必需的一步,这些信号通路包括磷酸酶PTEN、SHP1和SHIP1、细胞因子信号传导抑制因子以及c-Mpl表面表达的下调。本综述将聚焦于正常和肿瘤性造血过程中的这些途径。

相似文献

1
Molecular mechanisms of thrombopoietin signaling.血小板生成素信号传导的分子机制。
J Thromb Haemost. 2009 Jul;7 Suppl 1:235-8. doi: 10.1111/j.1538-7836.2009.03419.x.
2
Systems biology of megakaryocytes.巨核细胞的系统生物学
Adv Exp Med Biol. 2014;844:59-84. doi: 10.1007/978-1-4939-2095-2_4.
3
Thrombopoietin signal transduction: studies from cell lines and primary cells.血小板生成素信号转导:来自细胞系和原代细胞的研究
Methods. 1999 Mar;17(3):238-49. doi: 10.1006/meth.1998.0734.
4
Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells.血小板生成素根据BaF-3细胞中活化的Mpl阈值水平产生不同影响。
J Cell Sci. 2002 Jun 1;115(Pt 11):2329-37. doi: 10.1242/jcs.115.11.2329.
5
The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway.血小板生成素受体可在不激活Jak-STAT信号通路的情况下介导细胞增殖。
J Exp Med. 1997 Dec 15;186(12):1947-55. doi: 10.1084/jem.186.12.1947.
6
Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.Lnk抑制血小板生成素-巨核细胞系生长因子信号传导以及血小板生成素介导的巨核细胞生成。
J Exp Med. 2004 Sep 6;200(5):569-80. doi: 10.1084/jem.20040762. Epub 2004 Aug 30.
7
Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.鉴定和表征一种具有高亲和力与 TPO 结合的 Mpl 剪接变异体及其对 ERK1/2 信号的激活。
Int J Biochem Cell Biol. 2013 Dec;45(12):2852-63. doi: 10.1016/j.biocel.2013.09.010. Epub 2013 Oct 19.
8
Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.血小板生成素,而非与gp130蛋白偶联受体结合的细胞因子,可激活正常人CD34+细胞、巨核细胞和血小板中的MAPKp42/44、AKT及STAT蛋白。
Exp Hematol. 2002 Jul;30(7):751-60. doi: 10.1016/s0301-472x(02)00810-x.
9
Thrombopoietin signal transduction requires functional JAK2, not TYK2.血小板生成素信号转导需要功能性的JAK2,而非TYK2。
J Biol Chem. 1999 May 7;274(19):13480-4. doi: 10.1074/jbc.274.19.13480.
10
A novel MPL point mutation resulting in thrombopoietin-independent activation.一种导致血小板生成素非依赖性激活的新型MPL点突变。
Leukemia. 2002 Aug;16(8):1500-6. doi: 10.1038/sj.leu.2402554.

引用本文的文献

1
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms.关于 c-Myeloproliferative Leukaemia (c-MPL) 基因及其异构体的功能特征的综述。
Cell Oncol (Dordr). 2024 Oct;47(5):1607-1626. doi: 10.1007/s13402-024-00988-w. Epub 2024 Sep 16.
2
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells.艾曲泊帕可增强间充质干/基质细胞的造血支持能力。
Ther Adv Hematol. 2022 Dec 26;13:20406207221142137. doi: 10.1177/20406207221142137. eCollection 2022.
3
Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice.
血小板生成素受体Mpl的内吞作用调节小鼠巨核细胞和红细胞的成熟。
Front Oncol. 2022 Aug 30;12:959806. doi: 10.3389/fonc.2022.959806. eCollection 2022.
4
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.系统文献回顾和荟萃分析:促血小板生成药物治疗化疗诱导性血小板减少症的应用
PLoS One. 2022 Jun 9;17(6):e0257673. doi: 10.1371/journal.pone.0257673. eCollection 2022.
5
miR-486-5p and miR-22-3p Enable Megakaryocytic Differentiation of Hematopoietic Stem and Progenitor Cells without Thrombopoietin.miR-486-5p 和 miR-22-3p 在没有血小板生成素的情况下促进造血干细胞和祖细胞向巨核细胞分化。
Int J Mol Sci. 2022 May 11;23(10):5355. doi: 10.3390/ijms23105355.
6
[Role of imbalance of M1/M2 subsets of bone marrow macrophages in the pathogenesis of immune-mediated aplastic anemia in mice].[骨髓巨噬细胞M1/M2亚群失衡在小鼠免疫介导的再生障碍性贫血发病机制中的作用]
Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):945-951. doi: 10.3760/cma.j.issn.0253-2727.2021.11.010.
7
In and out: Traffic and dynamics of thrombopoietin receptor.进出:血小板生成素受体的运输和动力学。
J Cell Mol Med. 2021 Oct;25(19):9073-9083. doi: 10.1111/jcmm.16878. Epub 2021 Aug 27.
8
c-Mpl and TPO expression in the human central nervous system neurons inhibits neuronal apoptosis.c-Mpl 和 TPO 在人中枢神经系统神经元中的表达抑制神经元凋亡。
Aging (Albany NY). 2020 Apr 27;12(8):7397-7410. doi: 10.18632/aging.103086.
9
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.血小板生成素受体激动剂艾曲波帕通过铁螯合抑制人巨细胞病毒复制。
Cells. 2019 Dec 20;9(1):31. doi: 10.3390/cells9010031.
10
Current Advance in Thrombopoietin Receptor Agonists in the Management of Thrombocytopenia Associated With Chronic Liver Disease: Focus on Avatrombopag.血小板生成素受体激动剂治疗慢性肝病相关性血小板减少症的研究进展:聚焦阿伐曲泊帕
Clin Med Insights Blood Disord. 2019 Oct 21;12:1179545X19875105. doi: 10.1177/1179545X19875105. eCollection 2019.